Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2010
12/08/2010EP1652925B1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION
12/08/2010EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1494693B1 Cripto-specific antibodies
12/08/2010EP1458759B1 Human antibodies against human glycoprotein vi and their use
12/08/2010EP1455821B1 Parathyroid hormone antibodies and related methods
12/08/2010EP1443958B1 Vaccine against infectious disease
12/08/2010EP1395284B1 Non-depleting anti-CD4 antibody TRX1 and its uses
12/08/2010EP1270588B1 Novel collagen-like protein clac, precursor thereof and genes encoding the same
12/08/2010EP1082341B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN101910843A Reagent for detecting HIV-1 antigen and detection method
12/08/2010CN101910201A B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
12/08/2010CN101910200A Improved NOGO-A binding molecules and pharmaceutical use thereof
12/08/2010CN101910199A Fc variants with altered binding to FcRn
12/08/2010CN101910198A Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
12/08/2010CN101910197A Antibodies to the PCRV antigen of pseudomonas aeruginosa
12/08/2010CN101909647A Use of TrkB antibodies for the treatment of respiratory disorders
12/08/2010CN101907623A Method for detecting gentamicin and/or micronomicin and special quantum dot fluorescence immunoassay kit thereof
12/08/2010CN101906161A Anti-human coagulation factor VII monoclonal antibody, preparation method thereof and use thereof
12/08/2010CN101906160A Human blood coagulation factor VIII resisting monoclonal antibody as well as preparation method and application thereof
12/08/2010CN101906159A Hybridoma cell line D6D
12/08/2010CN101905024A Composition comprising and method of using angiopoietin-like protein 3 ANGPTl3
12/08/2010CN101597595B Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3
12/08/2010CN101210050B Antibodies for preventing bloodvessel endothelium growth factor
12/07/2010US7848487 Methods for sterilizing biological materials containing non-aqueous solvents
12/07/2010US7847119 Drug conjugates
12/07/2010US7847082 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
12/07/2010US7847080 Expression vector comprising nucleotide sequences coding novel g-protein coupled receptors for identifying modulators of sweet taste transduction
12/07/2010US7847071 Antibody purification by protein a and ion exchange chromatography
12/07/2010US7847070 to identify antagonists of human antigen LUCA2 a disease and cancer-associated antigen; anticancer agents
12/07/2010US7847069 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7847067 treats hematologic malignancies, cancer; scFv antibody
12/07/2010US7847066 High throughput screening; immunoassays; immunogens; antibodies producing uridine diphosphate with higher affinity to carbohydrates
12/07/2010US7846737 Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
12/07/2010US7846725 Mammalian cell demonstrating GDP-mannose 4,6-dehydratase (GMD) suppression and which expresses immunoglobulin associated with antibody-dependent cellular cytotoxicity; targeted treatment of tumors
12/07/2010US7846679 Methods for detecting the presence of mutant mammalian presenilin protein
12/07/2010US7846673 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas
12/07/2010US7846672 Method for detecting the affinity of folate receptor auto antibodies
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846450 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection
12/07/2010US7846444 treating interleukin-22 (IL-22)-associated disorder such as arthritis or psoriasis by administering the antibody in an amount sufficient to inhibit or reduce immune cell activity in the subject
12/07/2010US7846443 Antibodies to IL-17A
12/07/2010US7846442 Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
12/07/2010US7846441 Treatment with anti-ErbB2 antibodies
12/07/2010US7846440 Antibodies against ErbB3 and uses thereof
12/07/2010US7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010US7846433 Methods of treating pre-eclampsia and eclampsia
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2264925C Purification of antigen-specific t cells
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138939A1 CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF
12/02/2010WO2010138803A2 Herv-k antigens, antibodies, and methods
12/02/2010WO2010138769A1 Amino acid sequences which enhance peptide conjugate solubility
12/02/2010WO2010138736A2 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/02/2010WO2010138621A2 Diagnosing and treating iga nephropathy
12/02/2010WO2010138564A1 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
12/02/2010WO2010138184A2 Avian derived antibodies
12/02/2010WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component
12/02/2010WO2010137295A1 Cdc45l peptides and vaccines including the same
12/02/2010WO2010137020A1 Methods of treating inflammation
12/02/2010WO2010136598A1 A collection and methods for its use
12/02/2010WO2010136577A1 Stim2-mediated capacitive calcium entry
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010WO2010136492A2 Antigen-binding proteins
12/02/2010WO2010136485A1 Antigen-binding proteins
12/02/2010WO2010136483A2 Antigen-binding proteins
12/02/2010WO2010136482A1 Antigen-binding proteins
12/02/2010WO2010136481A1 Il-13 binding protein
12/02/2010WO2010136480A1 Antigen-binding proteins
12/02/2010WO2010136311A2 Compositions and methods for antibodies targeting complement protein c3b
12/02/2010WO2010136196A1 Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders
12/02/2010WO2010136172A1 Tri- or tetraspecific antibodies
12/02/2010WO2010135786A1 A method for diagnosing neoplasms and molecules for use therein
12/02/2010WO2010116196A3 Diagnosisof and treatment gluten-induced autoimmune diseases
12/02/2010WO2010115843A3 Pharmaceutical composition
12/02/2010WO2010111254A9 NOVEL ANTI-α5β1 ANTIBODIES AND USES THEREOF
12/02/2010WO2010087743A3 The use of basigin-1 in stem cell and cancer applications
12/02/2010WO2010070145A3 Genetic immunization for producing immunoglobulins against cell-associated antigens such as p2x7, cxcr7 or cxcr4
12/02/2010WO2010068923A3 Agents that selectively inhibit cd25 on dendritic cells or t cells and their use
12/02/2010US20100306875 Resistance gene and uses thereof
12/02/2010US20100306867 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
12/02/2010US20100306864 Polypeptide having enhanced effector function
12/02/2010US20100306863 Screening, therapy and diagnosis
12/02/2010US20100305307 Human monoclonal antibodies to epidermal growth factor receptor
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305185 Diagnostic method
12/02/2010US20100305051 Natriuretic activities
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305029 Paralytic Peptide for Use in Neuromuscular Therapy
12/02/2010US20100305025 Rnase a peptides, fragments and uses thereof
12/02/2010US20100304419 Method for determining the prognosis of gastric cancer
12/02/2010US20100304408 Use of the alpha chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
12/02/2010US20100304406 Protein Phosphorylation by Serine/Threonine Kinases in Insulin Signaling Pathways
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 1494